Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2023 Apr 7:7:27550834231163706.
doi: 10.1177/27550834231163706. eCollection 2023 Jan-Dec.

Impact of the COVID-19 pandemic on the consumption patterns of psychotropic drugs and predictors of limited access to medication

Maya Rachidi  1 , Georges Hatem  1   2 , Melissa Hatem  3 , Salam Zein  1 , Samar Rachidi  1 , Sanaa Awada  1
Affiliations

Impact of the COVID-19 pandemic on the consumption patterns of psychotropic drugs and predictors of limited access to medication

Maya Rachidi et al. J Med Access. .

Abstract

Background: Despite the efforts of the health system to improve access to medications during the coronavirus disease of 2019 (COVID-19) pandemic, such as online consultations, encouraging generic prescriptions, and other measures to limit the storage of medication, psychotropic patients faced significant challenges in accessing their medications.

Objectives: This study aimed (1) to compare the consumption of psychotropics before and during the pandemic, (2) to assess the association between having difficulties finding the medications and the general characteristics of the patients, and (3) to assess the predictors of these difficulties.

Design: A case-control study was performed in which 128 patients (cases) were recruited during the pandemic (July-October 2021), and 256 patients (controls) using psychotropics before the pandemic were matched for age and sex.

Methods: Data were collected using a uniform survey given to patients using psychotropics and filled out at their time and place preferences.

Results: More patients used antipsychotics and anti-anxiety medications before the pandemic, while antidepressants were used more during the pandemic. Almost half of the patients reported facing difficulties finding their medications in both time frames. Before the pandemic, these difficulties were noted per increase in age and being employed and were less faced if patients had medical assistance or lived in the north of Lebanon. However, more patients reported having difficulties accessing their medication during the pandemic, with no significant differences.

Conclusion: The consumption of psychotropic drugs was higher among cases. All patients faced challenges in accessing their medication throughout the pandemic, while older and employed patients had more limitations before the pandemic. Further investigations exploring viable solutions are recommended in order to maintain sustainable access to treatment.

Keywords: COVID-19 pandemic; access to medication; patients; predictors; psychotropic medication; shortage of medication.

PubMed Disclaimer

Conflict of interest statement

The author(s) declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Figures

Figure 1.
Figure 1.
Comparison in psychotropic medications consumption before and during the COVID-19 pandemic.
See this image and copyright information in PMC

Similar articles

See all similar articles

Cited by

References

    1. Clement J, Jacobi M, Greenwood BN.Patient access to chronic medications during the Covid-19 pandemic: evidence from a comprehensive dataset of US insurance claims. PLoS ONE 2021; 16(4): e0249453. - PMC - PubMed
    1. Yao H, Chen JH, Xu YF.Patients with mental health disorders in the COVID-19 epidemic. Lancet Psychiatry 2020; 7: E21. - PMC - PubMed
    1. Kumar A, Nayar KR.COVID 19 and its mental health consequences. Milton Park, Abingdon: Taylor & Francis, 2021, p. 1-2. - PubMed
    1. Hossain MM, Tasnim S, Sultana A, et al.. Epidemiology of mental health problems in COVID-19: a review. F1000res 2020; 9: 636. - PMC - PubMed
    1. Păunescu RL, Miclu Ia IV, Verişezan OR, et al.. Acute and long‑term psychiatric symptoms associated with COVID‑19. Biomed Rep 2023; 18(1): 4–6. - PMC - PubMed

LinkOut - more resources